171 related articles for article (PubMed ID: 37666068)
41. Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions.
Siemińska I; Węglarczyk K; Surmiak M; Kurowska-Baran D; Sanak M; Siedlar M; Baran J
Front Immunol; 2021; 12():748097. PubMed ID: 34659245
[TBL] [Abstract][Full Text] [Related]
42. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.
Sahraei M; Bose M; Sanders JA; De C; DasRoy L; Nath S; Brouwer CR; Mukherjee P
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070449
[TBL] [Abstract][Full Text] [Related]
43. Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.
Binsfeld M; Muller J; Lamour V; De Veirman K; De Raeve H; Bellahcène A; Van Valckenborgh E; Baron F; Beguin Y; Caers J; Heusschen R
Oncotarget; 2016 Jun; 7(25):37931-37943. PubMed ID: 27177328
[TBL] [Abstract][Full Text] [Related]
44. Modified method for differentiation of myeloid-derived suppressor cells
Zhou H; Xie Z; Morikawa N; Sakurai F; Mizuguchi H; Okuzaki D; Okada N; Tachibana M
Biochem Biophys Rep; 2023 Mar; 33():101416. PubMed ID: 36605123
[TBL] [Abstract][Full Text] [Related]
45. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer.
Song J; Lee J; Kim J; Jo S; Kim YJ; Baek JE; Kwon ES; Lee KP; Yang S; Kwon KS; Kim DU; Kang TH; Park YY; Chang S; Cho HJ; Kim SC; Koh SS; Kim S
Oncotarget; 2016 Aug; 7(32):51840-51853. PubMed ID: 27322081
[TBL] [Abstract][Full Text] [Related]
46. Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer.
Okła K; Czerwonka A; Wawruszak A; Bobiński M; Bilska M; Tarkowski R; Bednarek W; Wertel I; Kotarski J
Front Immunol; 2019; 10():691. PubMed ID: 31001284
[TBL] [Abstract][Full Text] [Related]
47. Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma.
Pang X; Fan HY; Tang YL; Wang SS; Cao MX; Wang HF; Dai LL; Wang K; Yu XH; Wu JB; Tang YJ; Liang XH
PLoS One; 2020; 15(2):e0229089. PubMed ID: 32092078
[TBL] [Abstract][Full Text] [Related]
48. CD205
Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S
Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883
[TBL] [Abstract][Full Text] [Related]
49. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
[TBL] [Abstract][Full Text] [Related]
50. Eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation.
Zeng X; Liao G; Li S; Liu H; Zhao X; Li S; Lei K; Zhu S; Chen Z; Zhao Y; Ren X; Su T; Cheng AS; Peng S; Lin S; Wang J; Chen S; Kuang M
Hepatology; 2023 Apr; 77(4):1122-1138. PubMed ID: 35598182
[TBL] [Abstract][Full Text] [Related]
51. PMN-MDSCs accumulation induced by CXCL1 promotes CD8
Zhou X; Fang D; Liu H; Ou X; Zhang C; Zhao Z; Zhao S; Peng J; Cai S; He Y; Xu J
Cancer Lett; 2022 Apr; 532():215598. PubMed ID: 35176418
[TBL] [Abstract][Full Text] [Related]
52. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y
Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053
[TBL] [Abstract][Full Text] [Related]
53. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer.
Sasidharan Nair V; Saleh R; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Alajez NM; Abu Nada M; Elkord E
Clin Epigenetics; 2020 Jan; 12(1):13. PubMed ID: 31941522
[TBL] [Abstract][Full Text] [Related]
54. Maitake α-glucan promotes differentiation of monocytic myeloid-derived suppressor cells into M1 macrophages.
Masuda Y; Nakayama Y; Shimizu R; Naito K; Miyamoto E; Tanaka A; Konishi M
Life Sci; 2023 Mar; 317():121453. PubMed ID: 36709912
[TBL] [Abstract][Full Text] [Related]
55. Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis.
Qin G; Lian J; Huang L; Zhao Q; Liu S; Zhang Z; Chen X; Yue D; Li L; Li F; Wang L; Umansky V; Zhang B; Yang S; Zhang Y
Oncoimmunology; 2018; 7(7):e1442167. PubMed ID: 29900050
[No Abstract] [Full Text] [Related]
56. Continuous activation of polymorphonuclear myeloid-derived suppressor cells during pregnancy is critical for fetal development.
Shi M; Chen Z; Chen M; Liu J; Li J; Xing Z; Zhang X; Lv S; Li X; Zuo S; Feng S; Lin Y; Xiao G; Wang L; He Y
Cell Mol Immunol; 2021 Jul; 18(7):1692-1707. PubMed ID: 34099889
[TBL] [Abstract][Full Text] [Related]
57. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis.
Ruan WS; Feng MX; Xu J; Xu YG; Song CY; Lin LY; Li L; Lu YQ
Front Immunol; 2020; 11():1299. PubMed ID: 32719675
[No Abstract] [Full Text] [Related]
58. Apolipoprotein A-I Mimetic Peptide L-4F Suppresses Granulocytic-Myeloid-Derived Suppressor Cells in Mouse Pancreatic Cancer.
Peng M; Zhang Q; Liu Y; Guo X; Ju J; Xu L; Gao Y; Chen D; Mu D; Zhang R
Front Pharmacol; 2020; 11():576. PubMed ID: 32425796
[TBL] [Abstract][Full Text] [Related]
59. Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.
Tannenbaum CS; Rayman PA; Pavicic PG; Kim JS; Wei W; Polefko A; Wallace W; Rini BI; Morris-Stiff G; Allende DS; Hamilton T; Finke JH; Diaz-Montero CM
Cancer Immunol Res; 2019 Oct; 7(10):1687-1699. PubMed ID: 31439615
[TBL] [Abstract][Full Text] [Related]
60. Interferon Regulatory Factor 4 Regulates the Development of Polymorphonuclear Myeloid-Derived Suppressor Cells Through the Transcription of c-Myc in Cancer.
Yang Q; Xie H; Li X; Feng Y; Xie S; Qu J; Xie A; Zhu Y; Zhou L; Yang J; Hu X; Wei H; Qiu H; Qin W; Huang J
Front Immunol; 2021; 12():627072. PubMed ID: 33708218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
